Key Takeaways

Eli Lilly became the first healthcare company to hit a $1 trillion valuation (briefly on Nov. 21)

Its diabetes and weight loss drugs are driving the rapid growth

Demand for GLP-1 meds continues to skyrocket

MONDAY, Nov. 24, 2025 (HealthDay News) — Eli Lilly reached a major milestone Friday, becoming the first healthcare company in the world to hit a $1 trillion market value.

The drug company briefly crossed the trillion-dollar mark during morning trading before its stock pulled back slightly. Shares were last trading at around $1,048 each.

Eli Lilly is now just the second non-technology company in the U.S. to reach a $1 trillion value, after Warren Buffett’s Berkshire Hathaway .

Much of that growth comes from two blockbuster drugs: Mounjaro for diabetes and Ze

See Full Page